학술논문
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial
Document Type
Article
Author
Kim, Won Seog; Buske, Christian; Ogura, Michinori; Jurczak, Wojciech; Sancho, Juan-Manuel; Zhavrid, Edvard; Kim, Jin Seok; Hernández-Rivas, José-Ángel; Prokharau, Aliaksandr; Vasilica, Mariana; Nagarkar, Rajinish; Osmanov, Dzhelil; Kwak, Larry W; Lee, Sang Joon; Lee, Sung Young; Bae, Yun Ju; Coiffier, Bertrand
Source
In The Lancet Haematology August 2017 4(8):e362-e373
Subject
Language
ISSN
2352-3026